Jonathan Goodman, MPhil

Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.

Early results appear promising for frontline asciminib in patients with chronic phase chronic myeloid leukemia, according to researchers.

Researchers sought to determine whether patient groups are accurately represented in clinical trials leading to the approval of drugs for patients with leukemia or MM.

Researchers sought to determine whether a standardized palliative care consultation system would improve follow-up throughout the duration of a patient’s illness.

Researchers sought to determine whether first-line rituximab plus bendamustine followed by ASCT would be an effective treatment option for MCL.

Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.

Long-acting G-CSF can reduce the risk of hospitalization related to febrile neutropenia in patients with DLBCL treated with R-CHOP.

Researchers sought to determine whether PLM60 with pegaspargase would have efficacy in patients with extranodal natural killer/T-cell lymphoma.

Researchers sought to determine the long-term efficacy of cladribine in patients with hairy cell leukemia.

Researchers sought to determine whether adding brentuximab vedotin to AVD would improve survival in patients with stage III or IV Hodgkin lymphoma.